![]() HOJA INFORMATIVA PARA RECEPTORES Y CUIDADORES AUTORIZACIÓN DE USO DE EMERGENCIA DE LA VACUNA CONTRA EL COVID-19 DE MODERNA PARA PREVENIR LA ENFERMEDAD DEL CORONAVIRUS 2019 (COVID-19) EN NIÑOS DE 6 AÑOS A 11 AÑOS Translations of the Moderna Fact Sheet for Recipients and Caregivers for 6 through 11 years of age PHIẾU THỰC TẾ DÀNH CHO NGƯỜI NHẬN VÀ KHÁCH HÀNG KHẨN CẤP SỬ DỤNG SỰ CHO PHÉP CỦA THUỐC THÚ Y MODERNA COVID-19 ĐỂ PHÒNG NGỪA BỆNH LỖ CHÂN LÔNG 2019 (COVID-19) Ở CÁ NHÂN 6 THÁNG QUA 5 TUỔI 수혜자와 간병인을 위한 팩트 시트 6개월에서 5세 사이의 개인에 코로나 바이러스 질병 2019(COVID-19)를 예방하기 위한 모더나 COVID-19 백신의 긴급 사용 승인įACT SHEET PARA SA MGA TATANGGAP AT MGA NAG-AALAGA EMERGENCY USE AUTHORIZATION NG BAKUNANG MODERNA COVID-19 UPANG MAIWASAN ANG CORONAVIRUS DISEASE 2019 (COVID-19) SA MGA INDIBIDWAL 6 NA BUWAN HANGGANG 5 TAONG GULANG HOJA INFORMATIVA PARA RECEPTORES Y CUIDADORES AUTORIZACIÓN DE USO DE EMERGENCIA DE LA VACUNA CONTRA EL COVID-19 DE MODERNA PARA PREVENIR LA ENFERMEDAD DEL CORONAVIRUS 2019 (COVID-19) EN NIÑOS DE 6 MESES A 5 AÑOS Important Prescribing Information for Vaccine Providers on Vial Presentation Available to Provide Doses for Ages 6 Years Through 11 YearsĦ years through 11 years of age (purple border) Receipt of the most recent booster dose with any authorized or approved monovalent COVID-19 vaccine in individuals 6 years of age and older.Ħ months through 5 years of age (magenta border)Ħ months through 5 years of age (yellow border)Ħ years through 11 years of age (purple and teal border)Ħ months through 5 years (dark pink cap and label with yellow box)Ħ years and older (blue cap and gray border).Completion of primary vaccination with any authorized or approved COVID-19 vaccine in individuals 6 years of age and older, or.Completion of primary vaccination with the monovalent Moderna COVID-19 Vaccine in children 6 months through 5 years of age, or.Moderna COVID-19 Vaccine, Bivalent is authorized for use as a single booster dose to prevent COVID-19, administered at least 2 months after: Third primary series dose for individuals 6 months of age and older who have been determined to have certain kinds of immunocompromise.Two-dose primary series for individuals 6 months of age and older.Moderna COVID-19 Vaccine is a monovalent COVID-19 vaccine that is authorized for emergency use to prevent COVID-19 as a: A third primary series dose to individuals 12 years of age and older with certain kinds of immunocompromise.A two-dose primary series to individuals 12 years through 17 years of age.It is also authorized for emergency use to provide: Spikevax is a monovalent COVID-19 vaccine that is approved for use as a two-dose primary series for the prevention of COVID-19 in individuals 18 years of age and older. The vaccine has been known as the Moderna COVID-19 Vaccine, and will now be marketed as Spikevax, for the prevention of COVID-19 in individuals 18 years of age and older. On January 31, 2022, the FDA announced the second approval of a COVID-19 vaccine. Spikevax Information Fact Sheets and FAQs Fact Sheet Translations Información sobre las vacunas para el COVID-19
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |